{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:48:50Z","timestamp":1791024530491,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T00:00:00Z","timestamp":1375920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Bronchial carcinoids are pulmonary neuroendocrine cell-derived tumors comprising typical (TC) and atypical (AC) malignant phenotypes. The 5-year survival rate in metastatic carcinoid, despite multiple current therapies, is 14-25%. Hence, we are testing novel therapies that can affect the proliferation and survival of bronchial carcinoids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In vitro studies were used for the dose\u2013response (AlamarBlue) effects of acetazolamide (AZ) and sulforaphane (SFN) on clonogenicity, serotonin-induced growth effect and serotonin content (LC-MS) on H-727 (TC) and H-720 (AC) bronchial carcinoid cell lines and their derived NOD\/SCID mice subcutaneous xenografts. Tumor ultra structure was studied by electron microscopy. Invasive fraction of the tumors was determined by matrigel invasion assay. Immunohistochemistry was conducted to study the effect of treatment(s) on proliferation (Ki67, phospho histone-H3) and neuroendocrine phenotype (chromogranin-A, tryptophan hydroxylase).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Both compounds significantly reduced cell viability and colony formation in a dose-dependent manner (0\u201380 \u03bcM, 48 hours and 7 days) in H-727 and H-720 cell lines. Treatment of H-727 and H-720 subcutaneous xenografts in NOD\/SCID mice with the combination of AZ + SFN for two weeks demonstrated highly significant growth inhibition and reduction of 5-HT content and reduced the invasive capacity of H-727 tumor cells. In terms of the tumor ultra structure, a marked reduction in secretory vesicles correlated with the decrease in 5-HT content.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The combination of AZ and SFN was more effective than either single agent. Since the effective doses are well within clinical range and bioavailability, our results suggest a potential new therapeutic strategy for the treatment of bronchial carcinoids.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-13-378","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T10:14:09Z","timestamp":1375956849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines"],"prefix":"10.1186","volume":"13","author":[{"given":"Reza Bayat","family":"Mokhtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed S","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Adeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Cutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Yeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,8]]},"reference":[{"key":"4052_CR1","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/cncr.23883","volume":"113","author":"O Hauso","year":"2008","unstructured":"Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM: Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008, 113: 2655-2664. 10.1002\/cncr.23883.","journal-title":"Cancer"},{"key":"4052_CR2","first-page":"16","volume":"2","author":"S Pusceddu","year":"2010","unstructured":"Pusceddu S, Catena L, Valente M, Buzzoni R, Formisano B, Del Vecchio M, Ducceschi M, Tavecchio L, Fabbri A, Bajetta E: Long-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysis. J Thor Disease. 2010, 2: 16-20.","journal-title":"J Thor Disease"},{"key":"4052_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1634\/theoncologist.2008-0207","volume":"13","author":"SN Pinchot","year":"2008","unstructured":"Pinchot SN, Holen K, Sippel RS, Chen H: Carcinoid tumors. Oncologist. 2008, 13: 1255-1269. 10.1634\/theoncologist.2008-0207.","journal-title":"Oncologist"},{"key":"4052_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1634\/theoncologist.10-2-123","volume":"10","author":"JM Zuetenhorst","year":"2005","unstructured":"Zuetenhorst JM, Taal BG: Metastatic carcinoid tumors: a clinical review. Oncologist. 2005, 10: 123-131. 10.1634\/theoncologist.10-2-123.","journal-title":"Oncologist"},{"key":"4052_CR5","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/cncr.10592","volume":"94","author":"DJ Walther","year":"2002","unstructured":"Walther DJ, Peter JU, Bader M: 7-Hydroxytryptophan, a novel, specific, cytotoxic agent for carcinoids and other serotonin-producing tumors. Cancer. 2002, 94: 3135-3140. 10.1002\/cncr.10592.","journal-title":"Cancer"},{"key":"4052_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT: Interfering with pH regulation in tumors as a therapeutic strategy. Nat Rev Drug Discov. 2011, 10: 767-777. 10.1038\/nrd3554.","journal-title":"Nat Rev Drug Discov"},{"key":"4052_CR7","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","volume":"64","author":"N Robertson","year":"2004","unstructured":"Robertson N, Potter C, Harris AL: Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res. 2004, 64: 6160-6165. 10.1158\/0008-5472.CAN-03-2224.","journal-title":"Cancer Res"},{"key":"4052_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/156802607780636708","volume":"7","author":"S Pastorekova","year":"2007","unstructured":"Pastorekova S, Kopacek J, Pastorek J: Carbonic anhydrase inhibitors and the management of cancer. Curr Top Med Chem. 2007, 7: 865-878. 10.2174\/156802607780636708.","journal-title":"Curr Top Med Chem"},{"key":"4052_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1677\/ERC-09-0085","volume":"17","author":"Y Arvidsson","year":"2010","unstructured":"Arvidsson Y, Bergstrom A, Arvidsson L, Kristansson E, Ahlman H, Nilsson O: Hypoxia stimulates CXCR4 signaling in ileal carcinoids. Endocr Relat Cancer. 2010, 17: 303-316. 10.1677\/ERC-09-0085.","journal-title":"Endocr Relat Cancer"},{"key":"4052_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT: Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008, 7: 168-181. 10.1038\/nrd2467.","journal-title":"Nat Rev Drug Discov"},{"key":"4052_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0010857","volume":"5","author":"S Carlin","year":"2010","unstructured":"Carlin S, Khan N, Ku T, Longo VA, Larson SM, Smith-Jones PM: Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts. PLoS One. 2010, 5: 1-9.","journal-title":"PLoS One"},{"key":"4052_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1124\/jpet.110.167270","volume":"334","author":"F Cianchi","year":"2010","unstructured":"Cianchi F, Vinci CM, Supuran CT, Peruzzi B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini A, Masini E, Puccetti L: Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells. J Pharmacol Exp Ther. 2010, 334: 710-719. 10.1124\/jpet.110.167270.","journal-title":"J Pharmacol Exp Ther"},{"key":"4052_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.1041500102","volume":"150","author":"J Ishizuka","year":"1992","unstructured":"Ishizuka J, Beauchamp RD, Townsend CMJR, Greeley GHJR, Thompson JC: Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol. 1992, 150: 1-7. 10.1002\/jcp.1041500102.","journal-title":"J Cell Physiol"},{"key":"4052_CR14","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1002\/cncr.24533","volume":"115","author":"I Drozdov","year":"2009","unstructured":"Drozdov I, Kidd M, Gustafsson BI, Svejda B, Joseph R, Pfragner R, Modlin IM: Auto-regulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines. Cancer. 2009, 115: 4934-4945. 10.1002\/cncr.24533.","journal-title":"Cancer"},{"key":"4052_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1113\/jphysiol.2001.013071","volume":"539","author":"XW Fu","year":"2002","unstructured":"Fu XW, Nurse CA, Wong V, Cutz E: Hypoxia-induced secretion of serotonin from intact pulmonary neuroepithelial bodies in neonatal rabbit. J Physiol. 2002, 539: 503-510. 10.1113\/jphysiol.2001.013071.","journal-title":"J Physiol"},{"key":"4052_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4161\/cc.3.2.618","volume":"3","author":"C Potter","year":"2004","unstructured":"Potter C, Harris AL: Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle. 2004, 3: 164-167.","journal-title":"Cell Cycle"},{"key":"4052_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1152\/ajpcell.2001.280.3.C581","volume":"280","author":"LJ Alvarez","year":"2001","unstructured":"Alvarez LJ, Turner HC, Zamudio AC, Candia OA: Serotonin-elicited inhibition of Cl- secretion in the rabbit conjunctival epithelium. Am J Physiol Cell Physiol. 2001, 280: 581-592.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4052_CR18","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-09-2937","volume":"16","author":"Y Li","year":"2010","unstructured":"Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, Sun D: Sulforaphane, a dietary component of broccoli\/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 2010, 16: 2580-2590. 10.1158\/1078-0432.CCR-09-2937.","journal-title":"Clin Cancer Res"},{"key":"4052_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1158\/1535-7163.MCT-06-0404","volume":"6","author":"D Chaudhuri","year":"2007","unstructured":"Chaudhuri D, Orsulic S, Ashok BT: Antiproliferative activity of sulforaphane in akt-overexpressing ovarian cancer cells. Mol Cancer Ther. 2007, 6: 334-345. 10.1158\/1535-7163.MCT-06-0404.","journal-title":"Mol Cancer Ther"},{"key":"4052_CR20","first-page":"6656","volume":"61","author":"M Fujimori","year":"2001","unstructured":"Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T: Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res. 2001, 61: 6656-6659.","journal-title":"Cancer Res"},{"key":"4052_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jamcollsurg.2009.03.006","volume":"209","author":"SC Pitt","year":"2009","unstructured":"Pitt SC, Chen H, Kunnimalaiyaan M: Phosphatidylinositol 3-kinase-akt signaling in pulmonary carcinoid cells. J Am Coll Surg. 2009, 209: 82-88. 10.1016\/j.jamcollsurg.2009.03.006.","journal-title":"J Am Coll Surg"},{"key":"4052_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1207\/s15327914nc4802_10","volume":"48","author":"G Parnaud","year":"2004","unstructured":"Parnaud G, Li P, Cassar G, Rouimi P, Tulliez J, Combaret L, Gamet-Payrastre L: Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer. 2004, 48: 198-206. 10.1207\/s15327914nc4802_10.","journal-title":"Nutr Cancer"},{"key":"4052_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-2187-5-10","volume":"5","author":"SK Roy","year":"2010","unstructured":"Roy SK, Srivastava RK, Shankar S: Inhibition of PI3K\/AKT and MAPK\/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 2010, 5: 1-13. 10.1186\/1750-2187-5-1.","journal-title":"J Mol Signal"},{"key":"4052_CR24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/modpathol.3800176","volume":"17","author":"T Igarashi","year":"2004","unstructured":"Igarashi T, Jiang SX, Kameya T, Asamura H, Sato Y, Nagai K, Okayasu I: Divergent cyclin B1 expression and Rb\/p16\/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod Pathol. 2004, 17: 1259-1267. 10.1038\/modpathol.3800176.","journal-title":"Mod Pathol"},{"key":"4052_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1753-4887.2008.00065.x","volume":"66","author":"RH Dashwood","year":"2008","unstructured":"Dashwood RH, Ho E: Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutrition Review. 2008, 66: 36-38.","journal-title":"Nutrition Review"},{"key":"4052_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1245\/s10434-008-0194-6","volume":"16","author":"JT Adler","year":"2009","unstructured":"Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H: Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors. Ann Surg Oncol. 2009, 16: 481-486. 10.1245\/s10434-008-0194-6.","journal-title":"Ann Surg Oncol"},{"key":"4052_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ptr.2618","volume":"23","author":"XF Wang","year":"2009","unstructured":"Wang XF, Wu DM, Li BX, Lu YJ, Yang BF: Synergistic inhibitory effect of sulforaphane and 5-fluorouracil in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. Phytother Res. 2009, 23: 303-307. 10.1002\/ptr.2618.","journal-title":"Phytother Res"},{"key":"4052_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11064-009-0040-7","volume":"35","author":"H Jiang","year":"2009","unstructured":"Jiang H, Shang X, Wu H, Huang G, Wang Y, Al-Holou S, Gautam SC, Chopp M: Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem Res. 2009, 35: 152-161.","journal-title":"Neurochem Res"},{"key":"4052_CR29","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1158\/0008-5472.CAN-10-0066","volume":"70","author":"V Rausch","year":"2010","unstructured":"Rausch V, Liu L, Kallifatidis G, Baumann B, Mattern J, Gladkich J, Wirth T, Schemmer P, B\u00fcchler MW, Z\u00f6ller M, Salnikov AV, Herr I: Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res. 2010, 70: 5004-5013. 10.1158\/0008-5472.CAN-10-0066.","journal-title":"Cancer Res"},{"key":"4052_CR30","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1021\/jf301981n","volume":"60","author":"LC Lin","year":"2012","unstructured":"Lin LC, Yeh CT, Kuo CC, Lee CM, Yen GC, Wang LS, Wu CH, Yang WC, Wu AT: Sulforaphane potentiates the efficacy of Imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt\/\u03b2-catenin function. J Agric Food Chem. 2012, 60: 7031-7039. 10.1021\/jf301981n.","journal-title":"J Agric Food Chem"},{"key":"4052_CR31","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1158\/0008-5472.CAN-07-6171","volume":"68","author":"L Mastrangelo","year":"2008","unstructured":"Mastrangelo L, Cassidy A, Mulholland F, Wang W, Bao Y: Serotonin receptors, novel targets of sulforaphane identified by proteomic analysis in Caco-2 Cells. Cancer Res. 2008, 68: 5487-5491. 10.1158\/0008-5472.CAN-07-6171.","journal-title":"Cancer Res"},{"key":"4052_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/rcm.1415","volume":"18","author":"Z Yan","year":"2004","unstructured":"Yan Z, Caldwell GW, Zhao B, Reitz AB: A high-throughput monoamine oxidase inhibition assay using liquid chromatography with tandem mass spectrometry. Rapid Commun Mass Spectrom. 2004, 18: 834-840. 10.1002\/rcm.1415.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"4052_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.chembiol.2006.05.004","volume":"13","author":"MG Lee","year":"2006","unstructured":"Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R: Histone H3 lysine 4 demethylation is a target of nonselective anti depressive medications. Chem Biol. 2006, 13: 563-567. 10.1016\/j.chembiol.2006.05.004.","journal-title":"Chem Biol"},{"key":"4052_CR34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1634\/stemcells.2007-0724","volume":"26","author":"B Das","year":"2008","unstructured":"Das B, Tsuchida R, Malkin D, Koren G, Baruchel S, Yeger H: Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem cell. 2008, 26: 1818-1830. 10.1634\/stemcells.2007-0724.","journal-title":"Stem cell"},{"key":"4052_CR35","first-page":"4687","volume":"26","author":"HA Idikio","year":"2006","unstructured":"Idikio HA: Spindle checkpoint protein hMad2 and histone H3 phosphoserine 10 mitosis marker in pediatric solid tumors. Anticancer Res. 2006, 26: 4687-4694.","journal-title":"Anticancer Res"},{"key":"4052_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/CCO.0b013e32833adee2","volume":"22","author":"B Erikkson","year":"2010","unstructured":"Erikkson B: New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?. Curr Opin Oncol. 2010, 22: 381-386. 10.1097\/CCO.0b013e32833adee2.","journal-title":"Curr Opin Oncol"},{"key":"4052_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ijc.26396","volume":"130","author":"SE Al-Batran","year":"2012","unstructured":"Al-Batran SE, Ducreux M, Ohtsu A: mTOR as a therapeutic target in patients with gastric cancer. Int J Cancer. 2012, 130: 491-496. 10.1002\/ijc.26396.","journal-title":"Int J Cancer"},{"key":"4052_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1530\/ERC-10-0320","volume":"18","author":"M Dong","year":"2011","unstructured":"Dong M, Yao JC: mTOR inhibition, a potential novel approach for bronchial carcinoids. Endoc-Relat Cancer. 2011, 18: 115-118.","journal-title":"Endoc-Relat Cancer"},{"key":"4052_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/157339808785161314","volume":"27","author":"E Cutz","year":"2008","unstructured":"Cutz E, Yeger H, Pan J, Ito T: Pulmonary neuroendocrine cell system in health and disease. Curr Resp Med Rev. 2008, 27: 174-186.","journal-title":"Curr Resp Med Rev"},{"issue":"4","key":"4052_CR40","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1378\/chest.12-1108","volume":"143","author":"N Fazio","year":"2013","unstructured":"Fazio N, Granberg D, Grossman A, Saletan S, Klimovsky J, Panneerselvam A, Wolin EM: Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors analysis of the phase 3, randomized, placebo-controlled radiant-2 study. Chest. 2013, 143 (4): 955-962. 10.1378\/chest.12-1108.","journal-title":"Chest"},{"key":"4052_CR41","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1073\/pnas.040554897","volume":"97","author":"S Parkkila","year":"2000","unstructured":"Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, Pastorek J, Sly WS: Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA. 2000, 97: 2220-2224. 10.1073\/pnas.040554897.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4052_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/mt.2010.216","volume":"19","author":"G Kallifatidis","year":"2011","unstructured":"Kallifatidis G, Labsch S, Rausch V, Mattern J, Gladkich J, Moldenhauer G, Buchler MW, Salinkov AV, Herr I: Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther. 2011, 19: 188-195. 10.1038\/mt.2010.216.","journal-title":"Mol Ther"},{"key":"4052_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/i8030229","volume":"1","author":"X Li","year":"2007","unstructured":"Li X, Xiang Y, Ma B, Qi X: Effects of acetazolamide combined with or without NaHCO3 on suppressing neoplasm growth, metastasis and aquaporin-1(AQP1) protein expression. Int J Mol Sci. 2007, 1: 229-240.","journal-title":"Int J Mol Sci"},{"key":"4052_CR44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1677\/ERC-10-0157","volume":"17","author":"L Righi","year":"2010","unstructured":"Righi L, Volante M, Rapa I, Tavaglione V, Inzani F, Pelosi G, Papotti M: Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. Endocr Relat Cancer. 2010, 17: 977-987. 10.1677\/ERC-10-0157.","journal-title":"Endocr Relat Cancer"},{"key":"4052_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000337257","volume":"96","author":"Z Bago-Horvath","year":"2012","unstructured":"Bago-Horvath Z, Sieghart W, Grusch M, Lackner A, Hayden H, Pirker C, Komina O, W\u0119sierska-G\u0105dek J, Haitel A, Filipits M, Berger W, Schmid K: Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR\/AKT\/mTOR pathway. Neuroendocrinology. 2012, 96: 228-237. 10.1159\/000337257.","journal-title":"Neuroendocrinology"},{"key":"4052_CR46","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.bcp.2005.03.015","volume":"69","author":"J Jakub\u00edkov\u00e1","year":"2005","unstructured":"Jakub\u00edkov\u00e1 J, Sedl\u00e1k J, Mithen R, Bao Y: Role of PI3K\/Akt and MEK\/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2\/M arrest and cell death in Caco-2 cells. Biochem Pharmacol. 2005, 69: 1543-1552. 10.1016\/j.bcp.2005.03.015.","journal-title":"Biochem Pharmacol"},{"key":"4052_CR47","doi-asserted-by":"publisher","first-page":"e51251","DOI":"10.1371\/journal.pone.0051251","volume":"7","author":"K Suppipat","year":"2012","unstructured":"Suppipat K, Park CS, Shen Y, Zhu X, Lacorazza HD: Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS One. 2012, 7: e51251-10.1371\/journal.pone.0051251.","journal-title":"PLoS One"},{"key":"4052_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2009.03.004","volume":"282","author":"N Shafee","year":"2009","unstructured":"Shafee N, Kaluz S, Ru N, Stanbridge EJ: PI3K\/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Letter. 2009, 282: 109-115. 10.1016\/j.canlet.2009.03.004.","journal-title":"Cancer Letter"},{"key":"4052_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jcb.20633","volume":"97","author":"S Kaluz","year":"2006","unstructured":"Kaluz S, Kaluzov\u00e1 M, Stanbridge EJ: The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. J Cell Biochem. 2006, 97: 207-216. 10.1002\/jcb.20633.","journal-title":"J Cell Biochem"},{"key":"4052_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/chemse\/bjh038","volume":"29","author":"S Matsumoto","year":"2004","unstructured":"Matsumoto S, Tanimoto T, Yoshida S, Ikeda M, Takeda M, Saiki C, Shimazu Y, Aoba T, Nasu M, Suzuki K: Effects of acetazolamide and 4-Aminopyridine on CO2-induced slowly adapting pulmonary stretch receptor inhibition in rats. Chem Senses. 2004, 29: 351-361. 10.1093\/chemse\/bjh038.","journal-title":"Chem Senses"},{"key":"4052_CR51","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-08-0903","volume":"14","author":"S Shankar","year":"2008","unstructured":"Shankar S, Ganapathy S, Srivastava RK: Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res. 2008, 14: 6855-6866. 10.1158\/1078-0432.CCR-08-0903.","journal-title":"Clin Cancer Res"},{"key":"4052_CR52","first-page":"1061","volume":"274","author":"H Sawaoka","year":"1998","unstructured":"Sawaoka H, Kawano S, Tsuji S, Tsuji M, Gunawan ES, Takei Y, Nagano K, Hori M: Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol. 1998, 274: 1061-1067.","journal-title":"Am J Physiol"},{"key":"4052_CR53","doi-asserted-by":"publisher","first-page":"8948","DOI":"10.1523\/JNEUROSCI.1692-11.2011","volume":"31","author":"G Jafarau","year":"2011","unstructured":"Jafarau G, Xie Y, Kullyev A, Liang B, Sze YJ: Regulation of extrasynaptic 5-HT by SERT function in 5-HT-absorbing neurons underscores adaptation behavior in C. elegans. J Neurosci. 2011, 31: 8948-8957. 10.1523\/JNEUROSCI.1692-11.2011.","journal-title":"J Neurosci"},{"key":"4052_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1309\/AJCPDXFOPXGEF0RP","volume":"136","author":"K Tsuta","year":"2011","unstructured":"Tsuta K, Liu DC, Kalhor N, Wistuba II, Moran CA: Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. Am J Clin Pathol. 2011, 136: 252-259. 10.1309\/AJCPDXFOPXGEF0RP.","journal-title":"Am J Clin Pathol"},{"key":"4052_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/JTO.0b013e3181ca063b","volume":"5","author":"BG Skov","year":"2010","unstructured":"Skov BG, Holm B, Erreboe A, Skov T, Mellemgaard A: ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival. J Thorac Oncol. 2010, 5: 453-4599. 10.1097\/JTO.0b013e3181ca063b.","journal-title":"J Thorac Oncol"},{"key":"4052_CR56","volume-title":"The Evaluation of Drug Discovery from Traditional Medicines to Modern drugs. In Edited by Ravina E. Weinheim","author":"E Ravina","year":"2011","unstructured":"Ravina E: The Evaluation of Drug Discovery from Traditional Medicines to Modern drugs. In Edited by Ravina E. Weinheim. 2011, Germany: WILEY-VCH Verlag & Co. KGaA. Boschstr Press"},{"key":"4052_CR57","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/ptr.3397","volume":"25","author":"HG Jee","year":"2011","unstructured":"Jee HG, Lee KE, Kim JB, Shin HK, Youn YK: Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro. Phytother Res. 2011, 25: 1623-1628. 10.1002\/ptr.3397.","journal-title":"Phytother Res"},{"key":"4052_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-4598-9-47","volume":"9","author":"CS Bryant","year":"2010","unstructured":"Bryant CS, Kumar S, Chamala S, Shah J, Pal J, Haider M, Seward S, Qazi AM, Morris R, Semaan A, Shammas MA, Steffes C, Potti RB, Prasad M, Weaver DW, Batchu RB: Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells. Mol Cancer. 2010, 9: 10-16. 10.1186\/1476-4598-9-10.","journal-title":"Mol Cancer"},{"key":"4052_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2982.2010.01643.x","volume":"23","author":"M Camilleri","year":"2011","unstructured":"Camilleri M: LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil. 2011, 23: 193-200. 10.1111\/j.1365-2982.2010.01643.x.","journal-title":"Neurogastroenterol Motil"},{"key":"4052_CR60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpsychires.2009.08.015","volume":"23","author":"T Hobara","year":"2010","unstructured":"Hobara T, Uchida S, Otsuki K, Matsubara T, Funato H, Matsuo K, Suestsugi M, Watanabe Y: Altered gene expression of histone deacetylases in mood disorder patients. J Psychiatr Res. 2010, 23: 263-270.","journal-title":"J Psychiatr Res"},{"key":"4052_CR61","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/carcin\/bgm049","volume":"28","author":"S Brian Cornblatt","year":"2007","unstructured":"Brian Cornblatt S, Lingxiang Y, Albena T, Kostova D, Melanie E, Fahey JW, Singh NK, Min-Shue Chen A, Stierer T, Garrett-Mayer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K: Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 2007, 28: 1485-1490. 10.1093\/carcin\/bgm049.","journal-title":"Carcinogenesis"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-378\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:53:02Z","timestamp":1630551182000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,8]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4052"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-378","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,8]]},"assertion":[{"value":"28 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"378"}}